INTRODUCTION
============

Vitamin D is well known pleiotropic prohormone that plays a key role in various pathophysiologic processes and has multiple actions on various target tissues and organs in the human body. Apart from its primary influences on calcium homeostasis and bone metabolism that are required to maintain skeletal health, vitamin D also has an essential role in controlling cell differentiation, apoptosis and growth, and inflammatory, immunomodulatory and anticoagulant effects \[[@B1][@B2][@B3][@B4][@B5][@B6]\]. It thus shows associations with several clinical conditions including cardiovascular, renal, neuropsychological, infectious, immunologic, allergic, cardio-metabolic and malignant diseases \[[@B7][@B8][@B9][@B10][@B11][@B12]\].

A growing understanding of the various critical functions of vitamin D has generated considerable interest in terms of the clinical implications of its deficiency, particularly in critically ill patients, and shed new light on its potential as a therapeutic target. There have therefore been various studies on the association between a low vitamin D level and the severity of critical illnesses on patient admission, intensive care unit (ICU) morbidity, mortality, and the outcomes of therapeutic trials. However, the findings of prior studies of vitamin D conducted in critically ill children remain controversial \[[@B2][@B3][@B13][@B14][@B15][@B16][@B17][@B18][@B19][@B20]\]. Furthermore, there are currently no data on vitamin D in relation to in critically ill Korean children.

In our present study therefore, we evaluated the prevalence of VDD and the associations between the 25(OH) vitamin D levels on admission and the clinical condition among a population of critically ill Korean children.

SUBJECTS AND METHODS
====================

Patients
--------

This study was approved by the institutional review board of Asan Medical Center, Seoul, Korea (IRB number: 2019-0230). The requirement for parental consent was waived due to the retrospective nature of the analyses. All children who had been consecutively admitted to the 14-bed multidisciplinary pediatric medical intensive care unit (PICU) of our children\'s hospital between October 2017 and January 2019 were eligible for enrollment. Among these cases, all patients under 18 years with a 25(OH) Vitamin D level measurement on the first day of PICU admission were included in the study population.

Data collection
---------------

We retrospectively reviewed the medical records and available PICU database information for each of the enrolled pediatric patients. The data collected from these records were the baseline characteristics of the subjects including weight, height, and weight for height (WFH) z score, demographic data, information on preexisting medical disorders, underlying diseases, causes of PICU admission, duration of PICU and hospital stays, need for mechanical ventilator (MV) support, duration of MV support, and requirement for vasoactive drugs. We calculated the body mass index (BMI) in patients aged over 2 years. From the WFH z and BMI z scores, we defined a moderate to severe malnutrition state as a z score \< −2 \[[@B21][@B22]\].

Measurement of laboratory parameters
------------------------------------

Blood samples had been obtained as close as possible to the time of the PICU admission in all of the study subjects and were subjected to laboratory testing including routine CBC levels (white blood cell \[WBC\], hemoglobin \[Hg\], platelet \[plt\]), chemistry profiles (albumin, creatinine \[Cr\],total bilirubin \[tBi\], lactate), 25(OH) vitamin D levels, coagulation profiles (prothrombin time \[PT\], anti-thrombin III \[AT III\]), and C-reactive protein (CRP).

CBC, routine chemistry and coagulation profiles were measured using the XN-series instruments, c-8000 and CS-5000, respectively. The serum concentrations of 25(OH) vitamin D were measured by radioimmunoassay (DIAsource 25OH Vitamin D total-RIA-CT; DIAsource ImmunoAssays S.A., LouvainlaNeuve, Belgium) in accordance with the manufacturer\'s instructions.

We defined vitamin D insufficiency (VDI) as a 25(OH) vitamin D level \< 30 ng/mL, a vitamin D deficiency (VDD) as 10 ≤ 25(OH) vitamin D \< 20 ng/mL, and severe VDD as 25(OH) vitamin D \< 10 ng/mL \[[@B23][@B24][@B25][@B26]\].

To evaluate the severity of illness at the time of admission, make outcome predictions, and assess organ dysfunction, the pediatric risk of mortality (PRISM) III \[[@B27]\], pediatric multiple organ dysfunction syndrome (pMODS) \[[@B28]\] and pediatric sequential organ failure assessment (pSOFA) scores \[[@B29]\] were calculated using the poorest values documented within the first 24 hours after admission to the PICU. The International Society on Thrombosis and Hemostasis disseminated intravascular coagulation (ISTH DIC) score was calculated to evaluate the DIC and related clinical outcomes.

Statistical analysis
--------------------

Data were statistically analyzed using the Statistical Package for Social Science (SPSS) release 21.0 for Windows (SPSS, Chicago, IL). Continuous data were expressed as the mean ± SD or median and interquartile range, as appropriate. Categorical variables were expressed as percentages. We used the chi-square or Fisher\'s exact test to compare qualitative categorical variables between groups. To compare quantitative continuous variables, the two-tailed independent Student\'s *t* test was used if the data were normally distributed and the Mann-Whitney nonparametric *U* test was used if the variables demonstrated a non-normal distribution. We ran trend analysis for the two variables using a linear by linear association test. The Pearson\'s correlation coefficient was used in the context of normality to test univariable correlations, whereas the Spearman\'s ρ coefficient was used for correlation testing of non-normally distributed variables. Multivariate logistic regression analysis with backward elimination was conducted using variables yielding *P*-values \< 0.05 by univariate analysis to identify independent variables associated with the outcomes. Factors considered to be confounding were entered into multivariable binary logistic regression analysis for adjustment that age, sex, body weight, ISTH DIC score, pMODS score and gastrointestinal/hepatobiliary problems were included as covariates in the model. Model fits were assessed using the Hosmer-Lemeshow goodness of fit test. A non-significant value (*P* \> 0.05) for this test suggested the absence of a biased fit. Results were summarized as adjusted odds ratios and the respective 95% confidence intervals (CIs). For all analysis, variables with a two-sided *P*-value less than 0.05 were considered statistically significant.

RESULTS
=======

Baseline characteristics of the study patients
----------------------------------------------

A total of 172 critically ill children that presented at our hospital over a 16-month period were included in the current analysis, comprising 88 boys and 84 girls. The baseline characteristics of this study population are presented in [Table 1](#T1){ref-type="table"}. The median age and body weight at the time of PICU admission was 34 months (range, 1--227) and 11.6 kg (range, 2.56--109), respectively. The most common underlying diseases were gastrointestinal and hepatobiliary disorders (35/172, 21.2%). Respiratory failure (77/172, 46.4%) was the leading cause of PICU admission. The mean 25(OH) vitamin D level of the enrolled patients was 17.5 ± 12.8 ng/mL. There were 112 children in our current study population (65.1%) with VDD. Among these patients, 68 (39.5%) showed a 25(OH) vitamin D level \< 10 ng/mL, indicating severe VDD. Fifty nine (34.3%) patients were assessed as having a moderate to severe malnutrition status. The PICU mortality rate in the VDD group was 14.3%, which was higher than overall PICU mortality in the total study population (12.2%).

Factors associated with VDD
---------------------------

We compared the VDD and non-VDD groups (i.e. patients with a 25(OH) vitamin D level \> 20 ng/mL) and observed marked differences in age and weight at the time of PICU admission. In terms of laboratory findings, the hemoglobin (Hg), platelet (plt), CRP, serum albumin, total bilirubin (tBi), prothrombin time (PT) and anti-thrombin III (AT III), coagulation related parameters showed a significant association with VDD, as indicated in [Table 2](#T2){ref-type="table"}. These parameters also showed a statistically significant correlation with the 25(OH) vitamin D level ([Table 3](#T3){ref-type="table"}). Among the severity evaluation scores, the ISTH DIC and pMODS showed a statistically meaningful association with VDD. As the 25(OH) vitamin D level lowered, the plt, CRP, PT, AT III, ISTH DIC score and MODS score had a tendency to increase ([Fig. 1](#F1){ref-type="fig"}). In line with these observations, several laboratory values, particularly coagulation-related parameters, demonstrated a meaningful association with VDD, which also had a tendency to show a linear association with the 25(OH) vitamin D level i.e. the severity of the deficiency.

We found no definitive association in our current study series between the presence of VDD and seasonal variations in the PICU admission, the nutritional status of the child including moderate to severe malnutrition, requirement for MV support or vasoactive drug use, the duration of the PICU or hospital stay, or PICU mortality. By multivariate logistic regression analysis, the age at PICU admission, gastrointestinal/hepatobiliary problems, and the ISTH DIC and pMODS score were independently significantly associated with VDD ([Table 4](#T4){ref-type="table"}).

DISCUSSION
==========

Our current analyses have identified a far higher prevalence of VDD (65.1%) in critically ill Korean children than has been previously reported in other populations \[[@B17][@B20][@B26][@B30]\]. The pathophysiology and causes of VDD are probably multifactorial and quite complex. Previously reported risk factors for VDD include breastfed infants, living at high altitudes because of limited UV light exposure, dark skin and a high BMI due to a supposed sequestration of dietary vitamin D in the adipose tissue \[[@B2][@B24]\]. In addition, the prevalence of VDD can vary by geographical location, ethnicity, dietary habit, body composition and by different combinations of clinical comorbidities \[[@B23]\].

Our present analyses have revealed a statistically significant association between VDD and age, with a tendency toward an increased incidence with age. These findings are consistent with previous data showing that adolescent patients have a lower serum vitamin D level than younger patients \[[@B26][@B31]\].

As vitamin D is mainly directly synthesized by UV irradiation of the skin (\> 90%), several factors associated with this cutaneous synthesis were suggested as risk factors for VDD.One of these is seasonal variations in the serum vitamin D levels \[[@B14][@B32][@B33]\]. In our current study, VDD was found to be more prevalent in patients admitted during the colder seasons, but this was not statistically significant. Seasonal variation implies the contribution of sunlight exposure, which is affected by duration and intensity. This is also impacted by latitude, clothing, outdoor activity, use of sunscreen, and others \[[@B34][@B35]\]. We could not collect data on all of these factors in our current study. In addition, critically ill children may have limited opportunities to play outside or do outdoor activities compared to normal healthy children, which may be a potential confounding factor in relation to our present results.

Skin color is also known to be related to the cutaneous synthesis of vitamin D. Although there is still some controversy around this, darker skin has been reported to require more sun light to synthesize vitamin D than lighter skin and VDD is suggested to be more common in dark skinned populations \[[@B36][@B37][@B38]\].

In terms of ethnicity, as well as skin color, different types of clothing based on cultural backgrounds, dietary habits (lower intake of dairy products or other foods fortified with vitamin D), different vitamin D metabolism, the serum level of vitamin D binding protein (VDBP) and the varying prevalence of genetic polymorphisms could affect the vitamin D levels \[[@B39][@B40]\]. We included only Korean children in our current study series, among which the VDD prevalence could well be different to other ethnic populations.

The nutritional status of the patients, including overweight or moderate to severe malnutrition, was also not found to be significantly associated with VDD in this study.

As the concentration of 25(OH)vitamin D is 1000-fold higher than that of 1,25 (OH) vitamin D in plasma, and its half- life (nearly 2--3 weeks) is much longer than that of 1,25 (OH) vitamin D (only 4--24 hours), it is widely accepted that the 25(OH)vitamin D level better reflects the vitamin D status \[[@B7][@B41][@B42]\]. We thus evaluated VDD via the measurement of 25(OH) vitamin D in our current analysis. However, more than 85% of the 25(OH) vitamin D in serum is bound to VDBP, whilst 10--15% is bound to albumin and less than 1% is in a free state in the plasma \[[@B43]\]. As a consequence, the serum albumin level can affect the serum 25(OH) vitamin D level as shown by our present findings.

In our present analyses also, gastrointestinal/hepatobiliary problems showed significant associations with VDD. Although our pediatric series was very heterogeneous and included patients such as biliary atresia, varix bleeding, malnutrition, fulminant hepatitis and hepatic failure, all of these disorders could affect serum 25 (OH) vitamin D levels by affecting dietary vitamin D absorption from the intestine or suppressing the hepatic function of vitamin D metabolism causing increases in its circulating form, and in the production of vitamin D carrier proteins, albumin and VDBP \[[@B36][@B44][@B45]\].

In addition, there is growing interest in the genetic influences on the metabolism, transport, and binding of vitamin D to VDBP, and the vitamin D receptor, which may also influence the plasma vitamin D level and the prevalence of VDD \[[@B46][@B47][@B48][@B49]\]. Inherent differences in the serum vitamin D level should therefore not be overlooked in future studies of VDD.

In our current study series, the most remarkable findings were the prominent correlation between the vitamin D levels in the severely ill children and several coagulation-related factors and the ISTH DIC score. These results are consistent with previous reports on the anti-coagulant properties of vitamin D. Recently, there has been growing evidence for the adverse effects of VDD on coagulation, fibrinolysis and inflammation in numerous *in vitro* and animal studies, and in human studies. Vitamin D is a known potent inhibitor of anti-β2GPI antibody-mediated tissue factor expression in endothelial cells \[[@B50]\], which can influence the coagulation system. The clinical implications of this include a possible association with ischemic heart diseases, deep vein thrombosis, or other thrombogenic disorders \[[@B5][@B51][@B52]\]. Although these clinical conditions appear not to be as prevalent in pediatric patients, many other disorders including severe sepsis, infection, inflammation and malignancies are common in critically ill children and could result in the activation of coagulation. A strong and systemic activation of coagulation combined with the inhibition of physiological anticoagulant and fibrinolytic systems could lead to intravascular fibrin formation and consumption of procoagulants. The most severe disorder resulting from an imbalance of these systems is known as disseminated intravascular coagulation (DIC), which may contribute to multiple organ failure. In our present study, as we observed a significant correlation between the serum 25 (OH) vitamin D level and coagulation related factors, we calculated the ISTH DIC score and also found a significant association. Furthermore, the CRP and pMODS score also showed a statistically significant association with the 25(OH) vitamin D level in our current study population. Consistent with previous findings, the explanation for this may be that VDD is associated with inflammation, coagulation and related organ dysfunction. In addition, as vitamin D plays various roles through its receptors in as many as 30 different tissue and cell types in humans such as brain, heart, gonads, muscle, mononuclear cells, breast, prostate, small intestine, activated T and B lymphocytes \[[@B53]\], it could impact multiple bodily functions in many different ways. VDD could thus be associated with multiple organ dysfunctions that have a direct impact on PICU outcomes including morbidity, mortality and prognosis. Notably however, we did not find a significant correlation between VDD and the duration of MV support, the length of the PICU or hospital stay, or PICU mortality.

Our present study had several limitations of note. First, the subjects were all from a single tertiary children\'s hospital and included only critically ill pediatric patients who had been admitted over a 16 month period. This restricted the sample size and observation time, which prevented us from conducting more detailed subgroup analysis. In addition, we could necessarily only establish associations and not causality. Second, there had been no pre-illness or pre-admission vitamin D level measurements in our study population. This lack of a sequential evaluation of the vitamin D levels weakened any conclusions about VDD in terms of causality and clinical outcomes. There were also few precise data on nutrition or previous vitamin supplementation in the children. This also limited any meaningful assessment of serial changes in the vitamin D level. Third, blood samples for serum 25(OH) vitamin D evaluations were taken once only at the time of PICU admission, which could also have affected the results. Various genetic factors that were not assessed by our analysis but could have affected the vitamin D data also cannot be ignored.

Notwithstanding the aforementioned limitations, our present analyses had several notable strengths. To our knowledge, our current study is the first report to evaluate the prevalence of VDD and its associations with several clinical outcomes in critically ill Korean pediatric patients. As previously mentioned, as the serum vitamin D level can be influenced by ethnic differences, it could be meaningful to obtain baseline data for these Korean critically ill pediatric patients. As this was a single center study, the PICU management protocols were consistent across the study population, which reduces the possibility of confounding effects that could be present in a multicenter study.

In conclusion, there is a high prevalence of VDD in critically ill Korean children and there are significant associations between this condition and various clinical parameters, most notably gastrointestinal/hepatobiliary disorders, coagulation related factors, and the ISTH DIC score. Further large-scale studies aimed at understanding the complex pathophysiology of VDD and its association with critical illnesses and clinical outcomes are warranted.
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VDD, vitamin D deficiency; CRP, C-reactive peptide; ISTH DIC score, International Society on Thrombosis and Hemostasis disseminated intravascular coagulation score; pMODS, pediatric multiple organ dysfunction syndrome.](nrp-14-12-g001){#F1}

###### Baseline characteristics of the study population

![](nrp-14-12-i001)

  Variables                                       Total subjects (n = 172)
  ----------------------------------------------- --------------------------
  Sex (M : F)                                     88 : 84
  Age at the time of PICU admission (month)^1)^   34 (1-227)
  Weight at the time of PICU admission (kg)^1)^   11.6 (2.56-109)
  moderate to severe malnutrition, n (%)          59 (34.3%)
  PICU admission season, n (%)                    
   Winter and Spring                              95 (55.2)
   Summer and Fall                                77 (44.8)
  Underlying disease, n (%)                       
   Gastroenterologic/Hepatobiliary                19 (11.0)
   Hemato-oncologic                               37 (21.5)
   Neurologic                                     32 (18.6)
   Cardiac                                        29 (16.9)
   Respiratory                                    10 (5.8)
   Metabolic/Endocrine                            26 (15.1)
  Cause of PICU admission, n (%)                  
   Respiratory failure                            77 (46.4)
   Heart failure                                  20 (11.6)
   Gastrointestinal / hepatobiliary problems      27 (15.7)
  Use of mechanical ventilation, n; (%)           95 (55.2)
  Use of vasoactive drugs, n; (%)                 80 (47.3)
  Hospital day (days)^2)^                         42.9 ± 77.2
  PICU duration (days)^2)^                        11.2 ± 15.0
  Duration of MV support (days)^2)^               8.4 ± 11.0
  PICU mortality (%)                              12.2
  WBC (x 10^3^/μL)^2)^                            27.3 ± 82.2
  Hg (g/dL^)2^)                                   10.7 ± 2.5
  Platelet (x 10^3^/μL)^2)^                       254.9 ± 178.3
  CRP (mg/dL)^2)^                                 3.7 ± 7.2
  albumin (g/dL)^2)^                              3.2 ± 0.7
  Lactate (mmol/L)^2)^                            3.4 ± 7.8
  tBi (mg/dL)^2)^                                 1.9 ± 4.9
  PT (%)^2)^                                      64.1 ± 25.8
  ATIII (%)^2)^                                   71.0 ± 26.1
  25(OH) Vitamin D (ng/mL)^2)^                    17.5 ± 12.8
  Vitamin D deficiency, n (%)                     112 (65.1)
   severe vitamin D deficiency                    68 (39.5)
  ISTH DIC score^2)^                              2.6 ± 2.1
  PRISM III score^2)^                             12.0 ± 7.8
  pSOFA score^2)^                                 6.3 ± 3.1
  pMODS score^2)^                                 5.1 ± 3.0

^1)^Median and range (all such values)

^2)^Mean ± SD (all such values)

M, male; F, female; PICU, pediatric intensive care unit; n, number; MV, mechanical ventilation; WBC, white blood cell; Hg, hemoglobin; CRP, C-reactive peptide; tBi, total bilirubin; PT, prothrombin time; ATIII, anti-thrombin; CRP, C-reactive peptide; RDW, red blood cell distribution width; ISTH DIC score, international society on Thrombosis and Hemostasis Disseminated intravascular coagulation score; PRISM III, pediatric risk of mortality; pSOFA, pediatric sequential organ failure assessment; pMODS, pediatric multiple organ dysfunction syndrome.

###### Comparisons between the VDD and non-VDD subjects
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  Variables                                       Vitamin D deficiency group (25(OH) vitamin D \< 20) (n = 112)   Non-vitamin D deficiency group (25(OH) vitamin D ≥ 20) (n = 60)   *P*-value
  ----------------------------------------------- --------------------------------------------------------------- ----------------------------------------------------------------- -----------
  Sex (M : F)                                     57 : 55                                                         31 : 29                                                           0.525
  Age at the time of PICU admission (month)^1)^   61.0 (1-227)                                                    19 (1-194)                                                        \< 0.001
  Weight at the time of PICU admission (kg)^1)^   16.4 (2.56-109)                                                 8.7 (2.6-62.3)                                                    0.001
  moderate to severe malnutrition                 37 (62.7)                                                       22 (37.3)                                                         0.377
  PICU admission season, n (%)                                                                                                                                                      0.055
   Winter and Spring                              68 (71.6)                                                       27 (28.4)                                                         
   Summer and Fall                                44 (57.1)                                                       33 (42.9)                                                         
  Use of mechanical ventilation, n; (%)           55 (49.1)                                                       40 (66.7)                                                         0.036
  Use of vasoactive drugs, n; (%)                 52 (47.3)                                                       28 (47.5)                                                         \> 0.999
  Hospital day (days)^2)^                         41.7 ± 72.4                                                     44.8 ± 84.8                                                       0.813
  PICU duration (days)^2)^                        10.9 ± 16.9                                                     11.8 ± 11.2                                                       0.728
  Duration of MV support (days)^2)^               7.9 ± 10.5                                                      9.0 ± 11.9                                                        0.716
  PICU mortality (%)                              14.3                                                            8.3                                                               0.332
  WBC (x 10^3^/μL)^2)^                            28.3 ± 82.6                                                     25.4 ± 82.2                                                       0.827
  Hg (g/dL)^2)^                                   10.5 ± 2.6                                                      11.2 ± 2.0                                                        0.048
  Platelet (x 10^3^/μL)^2)^                       223.5 ± 156.1                                                   313.6 ± 202.1                                                     0.003
  CRP (mg/dL)^2)^                                 4.4 ± 8.1                                                       2.2 ± 4.8                                                         0.029
  albumin (g/dL)^2)^                              3.1 ± 0.7                                                       3.3 ± 0.6                                                         0.032
  Lactate (mmol/L)^2)^                            3.7 ± 9.5                                                       3.0 ± 2.7                                                         0.595
  Cr (mg/dL)^2)^                                  0.9 ± 1.7                                                       0.7 ± 1.3                                                         0.564
  tBi (mg/dL)^2)^                                 2.5 ± 5.9                                                       0.8 ± 2.0                                                         0.007
  PT (%)^2)^                                      58.7 ± 24.8                                                     71.2 ± 26.1                                                       0.003
  ATIII (%)^2)^                                   66.6 ± 26.7                                                     79.3 ± 23.0                                                       0.004
  ISTH DIC score^2)^                              3.0 ± 2.1                                                       1.9 ± 1.8                                                         0.001
  PRISM III score^2)^                             12.2 ± 7.8                                                      11.7 ± 7.9                                                        0.653
  pSOFA score^2)^                                 6.5 ± 3.2                                                       6.0 ± 3.0                                                         0.339
  pMODS score^2)^                                 5.4 ± 3.0                                                       4.4 ± 2.8                                                         0.035

^1)^Median and range (all such values)

^2)^Mean ± SD (all such values)

M, male; F, female; PICU, pediatric intensive care unit; n, number; MV, mechanical ventilation; WBC, white blood cell; Hg, hemoglobin; CRP, C-reactive peptide; Cr, creatinine; tBi, total bilirubin; PT, prothrombin time; ATIII, anti-thrombin; ISTH DIC score, international society on Thrombosis and Hemostasis Disseminated intravascular coagulation score; PRISM III, pediatric risk of mortality; pSOFA, pediatric sequential organ failure assessment; pMODS, pediatric multiple organ dysfunction syndrome.

###### Spearman\'s rho coefficients for the 25(OH) vitamin D levels and other indicated parameters
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                     Hg          plt         CRP          tBI          PT sec       ATIII       ISTH DIC score   pMODS
  ------------------ ----------- ----------- ------------ ------------ ------------ ----------- ---------------- --------------
  rho coefficients   0.162^\*^   0.206^\*^   -0.268^\*^   -0.355^\*^   -0.333^\*^   0.291^\*^   -0.310^\*^       -0.205^\*\*^
  *P*-value          0.034       0.007       0.000        0.000        0.000        0.000       0.000            0.007

Hg, hemoglobin; plt, platelet; CRP, C-reactive peptide; tBi, total bilirubin; PT, prothrombin time; ATIII, anti-thrombin; ISTH DIC score, International Society on Thrombosis and Hemostasis disseminated intravascular coagulation score; pMODS, pediatric multiple organ dysfunction syndrome.

###### Multivariate logistic regression analysis of VDD
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  Covariate^1)^                             Unadjusted OR (95% CI)   *P*-value   Adjusted OR (95% CI)   *P*-value
  ----------------------------------------- ------------------------ ----------- ---------------------- -----------
  Age (months)                              1.009 (1.004-1.015)      0.001       1.010 (1.004-1.016)    0.001
  ISTH DIC score                            1.319 (1.113-1.563)      0.001       1.231 (1.021-1.484)    0.029
  pMODS score                               1.124 (1.006-1.257)      0.040       1.108 (0.980-1.254)    0.102
  Gastrointestinal/hepatobiliary problems   7.909 (1.800-34.747)     0.006       6.452 (1.412-29.476)   0.016

ISTH, International Society on Thrombosis and Hemostasis; DIC, disseminated intravascular coagulation; pMODS, pediatric multiple organ dysfunction syndrome; CI, confidence interval.

^1)^Sex and body weight included as covariates in the model.
